High-profile R&D specialist David Lebwohl jumps to new job as CMO of a pioneering CRISPR player; Troubled AMAG Pharmaceuticals taps Scott Myers as CEO
→ Novartis vet David Lebwohl has found a new biotech to ply his trade.
A little more than a year ago, Lebwohl joined the great …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.